MacroGenics Ownership | Who Owns MacroGenics?

Overview Forecast RevenueFinancials Chart Transcripts

MacroGenics Ownership Summary

MacroGenics is owned by 97.59% institutional investors, 2.64% insiders. Bellevue group is the largest institutional shareholder, holding 15.96% of MGNX shares. BB Biotech AG Ord is the top mutual fund, with 15.83% of its assets in MacroGenics shares.

MGNX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	MacroGenics	97.59%	2.64%	-0.23%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bellevue group	9.94M	15.96%	$42.25M
Armistice capital	6.00M	9.63%	$25.50M
Blackrock	5.40M	8.67%	$22.96M
Vanguard group	4.14M	6.64%	$17.58M
Millennium management	3.31M	5.32%	$14.08M
Frazier life sciences management	3.01M	4.83%	$12.80M
Wasatch advisors lp	2.45M	3.94%	$10.42M
State street	1.54M	2.48%	$6.56M
Geode capital management	1.42M	2.27%	$6.02M
Price t rowe associates inc /md/	1.34M	2.15%	$5.68M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bellevue group	9.94M	0.69%	$42.25M
Frazier life sciences management	3.01M	0.60%	$12.80M
Armistice capital	6.00M	0.32%	$25.50M
Vestal point capital, lp	800.00K	0.25%	$3.40M
Rock springs capital management lp	1.05M	0.13%	$4.48M
Tang capital management	218.86K	0.09%	$930.14K
Wasatch advisors lp	2.45M	0.06%	$10.42M
Pdt partners	110.75K	0.04%	$470.69K
Pinnacle associates	637.32K	0.04%	$2.71M
Virtus etf advisers	19.34K	0.04%	$82.21K

Top Buyers

Holder	Shares	% Assets	Change
Armistice capital	6.00M	0.32%	3.60M
Millennium management	3.31M	0.01%	3.22M
Wasatch advisors lp	2.45M	0.06%	1.46M
Two sigma investments, lp	1.22M	0.01%	1.21M
Two sigma advisers, lp	1.15M	0.01%	1.15M

Top Sellers

Holder	Shares	% Assets	Change
Avoro capital advisors	-	-	-6.15M
State street	1.54M	0.00%	-2.85M
T. rowe price investment management	-	-	-2.77M
Ra capital management	-	-	-2.08M
Price t rowe associates inc /md/	1.34M	0.00%	-1.10M

New Positions

Holder	Shares	% Assets	Change	Value
Two sigma advisers, lp	1.15M	0.01%	1.15M	$4.89M
Tang capital management	218.86K	0.09%	218.86K	$930.14K
D. e. shaw	114.06K	0.00%	114.06K	$484.75K
Pdt partners	110.75K	0.04%	110.75K	$470.69K
Hap trading	75.00K	0.00%	75.00K	$15.00K

Sold Out

Holder	Change
Financial gravity asset management	-2.00
Nelson, van denburg & campbell wealth management group	-13.00
Rothschild investment	-20.00
Innealta capital	-68.00
Capital advisors	-81.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	152	-10.59%	60,787,295	-6.23%	97	890450.81%	80	-16.67%	45	-8.16%
Mar 31, 2024	170	20.57%	64,823,065	5.10%	-	0.00%	96	26.32%	49	6.52%
Dec 31, 2023	141	11.02%	61,676,116	6.40%	99	1.13%	76	33.33%	46	-
Sep 30, 2023	127	-3.05%	57,964,119	-3.32%	93	1.00%	57	-	46	-2.13%
Jun 30, 2023	131	-5.76%	59,952,089	2.69%	96	1.09%	57	-16.18%	47	17.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
BB Biotech AG Ord	9.93M	15.83%	-
Vanguard Total Stock Mkt Idx Inv	2.00M	3.19%	-
Wasatch Ultra Growth	1.63M	2.60%	-
iShares Russell 2000 ETF	1.59M	2.53%	-3.57K
Vanguard Institutional Extnd Mkt Idx Tr	931.11K	1.48%	-75.00
Wasatch Micro Cap	773.76K	1.23%	98.76K
Fidelity Small Cap Index	629.95K	1.00%	-14.46K
State St Russell Sm/Mid Cp® Indx NL Cl C	482.50K	0.77%	-12.60K
iShares Russell 2000 Growth ETF	466.83K	0.74%	-
Delaware Healthcare I	420.00K	0.67%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 04, 2024	Peters Jeffrey Stuart	Senior VP and General Counsel	Sell	$2.28K
Apr 04, 2024	Peters Jeffrey Stuart	Senior VP and General Counsel	Sell	$3.80K
Apr 04, 2024	Peters Jeffrey Stuart	Senior VP and General Counsel	Sell	$94.93K
Apr 04, 2024	Peters Jeffrey Stuart	Senior VP and General Counsel	Sell	$57.67K
Apr 04, 2024	Peters Jeffrey Stuart	Senior VP and General Counsel	Sell	$640.48K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	5
2024 Q1	-	11
2023 Q4	1	1

MGNX Ownership FAQ

Who Owns MacroGenics?

MacroGenics shareholders are primarily institutional investors at 97.59%, followed by 2.64% insiders and -0.23% retail investors. The average institutional ownership in MacroGenics's industry, Biotech Stocks , is 44.97%, which MacroGenics exceeds.

Who owns the most shares of MacroGenics?

MacroGenics’s largest shareholders are Bellevue group (9.94M shares, 15.96%), Armistice capital (6M shares, 9.63%), and Blackrock (5.4M shares, 8.67%). Together, they hold 34.27% of MacroGenics’s total shares outstanding.

Does Blackrock own MacroGenics?

Yes, BlackRock owns 8.67% of MacroGenics, totaling 5.4M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.96M$. In the last quarter, BlackRock decreased its holdings by -294K shares, a -5.17% change.

Who is MacroGenics’s biggest shareholder by percentage of total assets invested?

Bellevue group is MacroGenics’s biggest shareholder by percentage of total assets invested, with 0.69% of its assets in 9.94M MacroGenics shares, valued at 42.25M$.

Who is the top mutual fund holder of MacroGenics shares?

BB Biotech AG Ord is the top mutual fund holder of MacroGenics shares, with 15.83% of its total shares outstanding invested in 9.93M MacroGenics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools